Nasdaq

ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg, First Needle-Free Epinephrine Treatment for Children Ages 4 and Up

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 mg, ...
Yahoo

FDA approves first non-needle treatment for severe allergic reactions

Add Yahoo as a preferred source to see more of our stories on Google. On August 9 the U.S. Food and Drug Administration (FDA) announced it had approved an epinephrine spray for emergency treatment of ...
The Washington Post

FDA approves needle-free alternative to EpiPen for allergic reactions

A newly approved nasal spray for serious allergic reactions will serve as a critical alternative to EpiPens and other auto-injectors, helping to treat such reactions quicker in people who are afraid ...
AOL

What It's Like To Try The First At-Home, Needle-Free Flu Vaccine

Back-to-school season is an exciting time of year, but it’s also the start of something no one likes: flu season. And in case you didn't already know: The top science-backed way to lower your risk of ...
Local 12 WKRC Cincinnati

No more needles? FDA approves first nasal spray to treat dangerous allergic reactions

(AP) - U.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen. The Food and Drug Administration said it ...